[Asia Economy Reporter Minji Lee] Samsung Engineering announced on the 29th that it has secured the EDISON IV project with Samsung Biologics, valued at 1,021.33 billion KRW. This amounts to 14.85% of last year's sales revenue. The contract end date is December 29, 2023.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing